Europe Peripheral Embolization Coils Market Forecast to 2031 - Regional Analysis

Description

List of Tables

The Europe peripheral embolization coils market was valued at US$ 189.47 million in 2023 and is expected to reach US$ 268.44 million by 2031; it is estimated to register a CAGR of 4.5% from 2023 to 2031.

Increase in Incidence of Cancer Drives Europe Peripheral Embolization Coils Market

Colorectal, prostate, lung, and cervical cancer are the most common types of cancer. According to the World Health Organization (WHO), ~20 million new cancer cases and 9.7 million cancer-related fatalities were reported in 2022. Moreover, approximately 53 million cancer patients exhibited a five-year survival rate after diagnosis. Nearly 1 in 5 people develop cancer in their lifetime; 1 in 9 men and 1 in 12 women die due to cancer. According to the same source, new cancer cases are estimated to reach the count of ~35 million by 2050, with a 77% increase from the number of cases reported in 2022. The coil embolization technique is widely used to treat patients suffering from lung cancer, liver cancer, neuroendocrine tumors, renal cancer, and cervical cancer, as the embolization coil blocks or stops the flow of blood to a tumor or tissue abnormality. Both detachable and pushable embolizing coils can be used to fill or close blood vessels. The pushable coils are mechanical embolic agents used in arteries and veins for various indications, including controlling bleeding, occluding vascular lesions such as aneurysms and arteriovenous fistulas, and redistributing blood flow to protect non-target vessels. Embolization with coils helps prevent the growth of aneurysms and tumors, thus mitigating their ability to harm essential organs. Thus, the rising prevalence of cancer cases creates a high demand for peripheral embolization coils.

Europe Peripheral Embolization Coils Market Overview

The Europe peripheral embolization coils market is further segmented into Germany, the UK, France, Italy, Spain, and the Rest of Europe. Europe occupies a significant position in the global peripheral embolization coils market and is expected to record a strong growth rate during the forecast period. The market growth in the region is mainly attributed to the burgeoning cases of colorectal cancer and gastrointestinal bleeding. According to GLOBOCAN 2020, Germany recorded ~57,528 new colorectal cases (including 26,654 women and 30,874 men) in 2020; nearly one in eight of these cases show cancerous growth in the large intestine (colon) or rectum in clinical evaluation. According to an article released by the National Institutes of Health (NIH), acute gastrointestinal bleeding (AGIB) is a prevalent surgical problem, accounting for ~85,000 occurrences per year in the UK, i.e., 1 case every 6 minutes. The lower gastrointestinal bleeding (LGIB) has an estimated annual incidence of 87 per 10,000 persons. The overall mortality rate for such patients varies from 3.4% to 17.8% for inpatients. Embolization is currently advocated as the initial step in the treatment of acute, life-threatening LGIB when an endoscopic approach proves to be impossible or ineffective. Detachable coils (with or without a triaxial system), as well as liquid embolic agents, have proven to be more effective than other embolic agents.

Varicose veins (bulging, overfilled veins) are highly common among women, particularly during pregnancy and in women over the age of 65. According to Statista, more than 500,000 women aged 65-74 in Spain were diagnosed with varicose veins in 2020. Varicocele embolization is an outpatient treatment that requires minimal recovery time. During the process, a small nick is made in the skin (typically in the groin). Metal coils are put into the catheter before being guided into the varicocele's varicose veins. This effectively closes up the damaged veins and redirects blood flow back to the circulatory system via a different route through healthy veins. Rest of Europe includes developing countries such as Poland, Austria, Switzerland, Sweden, Norway, Ireland, Denmark, Belgium, and the Netherlands. As per the Global Cancer Observatory data, a total of 9,585 new colorectal cancer cases were diagnosed in Belgium in 2020, including 4,150 cases in women and 5,435 in men. Further, nearly 4,976 new colorectal cancer cases in Norway were diagnosed in 2020. In Switzerland, approximately 4,569 new colorectal cancer cases were diagnosed in 2020. One of the common complications of colorectal cancer is GIB, which is typically related to primary tumor erosion and hemorrhage. Microcoil embolization is an effective method for decreasing GIB. Pushable coils are the most common embolic agent utilized in both upper and lower gastrointestinal hemorrhage.

Europe Peripheral Embolization Coils Market Revenue and Forecast to 2031 (US$ Million)

Europe Peripheral Embolization Coils Market Segmentation

The Europe peripheral embolization coils market is categorized into type, material, application, and country.

Based on type, the Europe peripheral embolization coils market is bifurcated into detachable coil and pushable coil. The detachable coil segment held a larger market share in 2023.

In terms of material, the Europe peripheral embolization coils market is categorized into platinum, platinum & hydrogel, and platinum tungsten alloy. The platinum segment held the largest market share in 2023.

By application, the Europe peripheral embolization coils market is segmented into bleedings & trauma, malformations, tumours, visceral aneurysm, endoleak type II, and varicose veins. The bleedings & trauma segment held the largest market share in 2023.

Based on country, the Europe peripheral embolization coils market is segmented into the UK, Germany, France, Italy, Spain, and the Rest of Europe. Germany dominated the Europe peripheral embolization coils market share in 2023.

Medtronic Plc; Penumbra, Inc.; Balt; Boston Scientific Corp; Cook Medical Holdings LLC; Wallaby Medical; Spartan Micro Inc.; and Terumo Corp. are some of the leading companies operating in the Europe peripheral embolization coils market.

Product Code: BMIRE00031511

1. Introduction

1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. Europe Peripheral Embolization Coils Market - Key Market Dynamics

4.1 Market Drivers
- 4.1.1 Rise in Prevalence of Aortic Aneurysm
- 4.1.2 Increase in Incidence of Cancer
4.2 Market Restraints
- 4.2.1 Complications Arising During or After Embolization
4.3 Market Opportunities
- 4.3.1 Expanding Range of Applications of Embolization Coils
4.4 Future Trends
- 4.4.1 Growing Importance of Packing Density
4.5 Impact of Drivers and Restraints:

5. Peripheral Embolization Coils Market - Europe Analysis

5.1 Europe Peripheral Embolization Coils Market Overview
5.2 Peripheral Embolization Coils Market Revenue (US$ Million), 2021-2031
5.3 Peripheral Embolization Coils Market Forecast Analysis
5.4 Peripheral Embolization Coils Market: Company Positioning

6. Europe Peripheral Embolization Coils Market Analysis - by Product Type

6.1 Overview
6.2 Detachable Coil
- 6.2.1 Overview
- 6.2.2 Detachable Coil: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
6.3 Pushable Coil
- 6.3.1 Overview
- 6.3.2 Pushable Coil: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)

7. Europe Peripheral Embolization Coils Market Analysis - by Material

7.1 Overview
7.2 Platinum
- 7.2.1 Overview
- 7.2.2 Platinum: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
7.3 Platinum & Hydrogel
- 7.3.1 Overview
- 7.3.2 Platinum & Hydrogel: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Platinum Tungsten Alloy
- 7.4.1 Overview
- 7.4.2 Platinum Tungsten Alloy: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)

8. Europe Peripheral Embolization Coils Market Analysis - by Application

8.1 Overview
8.2 Bleedings & Trauma
- 8.2.1 Overview
- 8.2.2 Bleedings & Trauma: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
8.3 Malformations
- 8.3.1 Overview
- 8.3.2 Malformations: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Tumors
- 8.4.1 Overview
- 8.4.2 Tumors: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
8.5 Visceral Aneurysms
- 8.5.1 Overview
- 8.5.2 Visceral Aneurysms: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
8.6 Endoleak Type II
- 8.6.1 Overview
- 8.6.2 Endoleak Type II: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
8.7 Varicose Veins
- 8.7.1 Overview
- 8.7.2 Varicose Veins: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)

9. Europe Peripheral Embolization Coils Market - Country Analysis

9.1 Europe: Market Overview
- 9.1.1 Europe: Peripheral Embolization Coils Market Breakdown, by Key Country, 2023 and 2031 (%)
  - 9.1.1.1 Germany: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.1.1.1.1 Germany: Peripheral Embolization Coils Market Breakdown, by Product Type
    - 9.1.1.1.2 Germany: Peripheral Embolization Coils Market Breakdown, by Material
    - 9.1.1.1.3 Germany: Peripheral Embolization Coils Market Breakdown, by Application
  - 9.1.1.2 United Kingdom: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.1.1.2.1 United Kingdom: Peripheral Embolization Coils Market Breakdown, by Product Type
    - 9.1.1.2.2 United Kingdom: Peripheral Embolization Coils Market Breakdown, by Material
    - 9.1.1.2.3 United Kingdom: Peripheral Embolization Coils Market Breakdown, by Application
  - 9.1.1.3 France: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.1.1.3.1 France: Peripheral Embolization Coils Market Breakdown, by Product Type
    - 9.1.1.3.2 France: Peripheral Embolization Coils Market Breakdown, by Material
    - 9.1.1.3.3 France: Peripheral Embolization Coils Market Breakdown, by Application
  - 9.1.1.4 Italy: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.1.1.4.1 Italy: Peripheral Embolization Coils Market Breakdown, by Product Type
    - 9.1.1.4.2 Italy: Peripheral Embolization Coils Market Breakdown, by Material
    - 9.1.1.4.3 Italy: Peripheral Embolization Coils Market Breakdown, by Application
  - 9.1.1.5 Spain: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.1.1.5.1 Spain: Peripheral Embolization Coils Market Breakdown, by Product Type
    - 9.1.1.5.2 Spain: Peripheral Embolization Coils Market Breakdown, by Material
    - 9.1.1.5.3 Spain: Peripheral Embolization Coils Market Breakdown, by Application
  - 9.1.1.6 Rest of Europe: Peripheral Embolization Coils Market - Revenue and Forecast to 2031 (US$ Million)
    - 9.1.1.6.1 Rest of Europe: Peripheral Embolization Coils Market Breakdown, by Product Type
    - 9.1.1.6.2 Rest of Europe: Peripheral Embolization Coils Market Breakdown, by Material
    - 9.1.1.6.3 Rest of Europe: Peripheral Embolization Coils Market Breakdown, by Application

10. Peripheral Embolization Coils Market-Industry Landscape

10.1 Overview
10.2 Growth Strategies in the Peripheral Embolization Coils Market
10.3 Inorganic Growth Strategies
- 10.3.1 Overview
10.4 Organic Growth Strategies
- 10.4.1 Overview

11. Company Profiles

11.1 Medtronic Plc
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Penumbra, Inc.
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Balt
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 Boston Scientific Corp
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 Cook Medical Holdings LLC
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 Wallaby Medical
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 Spartan Micro Inc.
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
11.8 Terumo Corp
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments

12. Appendix

12.1 About The Insight Partners
12.2 Glossary of Terms